- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Affymax Inc+ Add to Watchlist
AFFY:US0.8455 USD 0.0245 2.82%
As of 20:10:00 ET on 12/10/2013.
Company Profile for Affymax Inc (AFFY)
Affymax Inc. is a clinical-stage biopharmaceutical company. The Company develops peptide-based drugs for the treatment of serious and life-threatening conditions such as kidney disease and cancer.
Key Executives for Affymax Inc (AFFY)
|Richard M Brenner "Rich"Chief Executive Officer||J Weston Rose "Wes"President|
|Mark G ThompsonChief Financial Officer||Anne-Marie DuliegeChief Medical Officer|
|Christine ConroySenior VP:Regulatory Affairs||Michael Holfinger "Mike"VP:Manufacturing & CMC Dev|
|Grace U ShinSecretary/General Counsel|